S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.06 +3.03% Gold 4,681 +5.95% US 10-Year Treasury Yield 4.738 +0.30% S&P 500 7,674 -1.43% Nasdaq 26,180 -2.05% Dow Jones 53,277 -0.85% FTSE 100 10,817 +0.62% DAX 26,137 -1.15% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.06 +3.03% Gold 4,681 +5.95% US 10-Year Treasury Yield 4.738 +0.30%

LATEST

Why Indian retail options traders are having a tough time to defuse what Warren Buffett called lethal time bombs●ETMarkets Management Talk | CleanMax’s next growth phase: 1.5 GW capacity addition target, Rs 3,000 crore EBITDA by FY28, says Kuldeep Jain●ETMarkets NRI Talk| Rs 1 crore, 5-7 years: How NRIs should allocate across Indian equities, bonds, gold and alternatives, says Rohit Sarin●How a Treasury buyback tweak helped bitcoin surge 25% to nearly $80,000 in days●Premium bonds: more chance of win as NS&I ups prize fund rate again●Six investors reveal the biggest market risks — and one strategy they agree on●FPI return to India may be tactical, not structural yet: HSBC MF’s Venugopal Manghat●Cost-of-living crisis hits students hard on campus●Why Indian retail options traders are having a tough time to defuse what Warren Buffett called lethal time bombs●ETMarkets Management Talk | CleanMax’s next growth phase: 1.5 GW capacity addition target, Rs 3,000 crore EBITDA by FY28, says Kuldeep Jain●ETMarkets NRI Talk| Rs 1 crore, 5-7 years: How NRIs should allocate across Indian equities, bonds, gold and alternatives, says Rohit Sarin●How a Treasury buyback tweak helped bitcoin surge 25% to nearly $80,000 in days●Premium bonds: more chance of win as NS&I ups prize fund rate again●Six investors reveal the biggest market risks — and one strategy they agree on●FPI return to India may be tactical, not structural yet: HSBC MF’s Venugopal Manghat●Cost-of-living crisis hits students hard on campus●

Front Page

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

Yahoo Finance · 1d ago

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

Read the full story at Yahoo Finance →

More Front Page

Premium bonds: more chance of win as NS&I ups prize fund rate again

Business | The Guardian · 1h ago

Canada and US scramble to finalise trade deal ahead of midnight tariff deadline

EUROS · 5h ago

Amazon hikes Echo and Kindle prices amid AI-driven memory chip shortage

EUROS · 6h ago

Texas Court Reduces Alex Jones Defamation Damages to $6 Million as Liquidation Stalls

EUROS · 8h ago